Delivery Order SPE2DB22D1106-SPE2DB25FFBV5
- Not listed
- The Defense Logistics Agency awarded a $17,940.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO, a pharmaceutical product supplied in 1,800mg-30,000 unit vials. This non-set-aside competitive award, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,960.42 to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800mg-30,000 15ml pharmaceutical product. This firm fixed price, non-set-aside contract was awarded on August 12, 2025, with an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $89,703.15 firm fixed price delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product. The contract is unclassified as a set-aside and has an ultimate completion date of September 24, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency has awarded a delivery order valued at $59,802.10 to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg/30,000 IU 15ml pharmaceutical product. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. This delivery order is a...
- The Defense Logistics Agency has awarded a delivery order valued at $23,920.84 to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. This firm fixed-price delivery order, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, represents a non-competitive award and is performed at the vendor's location in Conshohocken, Pennsylvania. The contract is a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $478,416.80 to AmerisourceBergen Drug Corp for Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products. This firm fixed price delivery order, awarded on September 2, 2025, represents a non-competitive, competitively awarded procurement with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product. This firm fixed-price delivery order, valued at $59,802.10, was awarded on August 1, 2025, with an ultimate completion date of August 22, 2025. The contract represents a non-set-aside award issued under competitive procurement, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $35,881.26 to AmerisourceBergen Drug Corp for Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products. This firm fixed price delivery order, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, represents a competitive award with no set-aside designation. The products will be supplied to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $123,315.90 for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product on September 19, 2025, with an ultimate completion date of October 10, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This firm fixed-price delivery order, valued at $11,960.42, represents a non-competitive, non-set-aside procurement and is scheduled for completion by August 4, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFBV5Delivery Order
The Defense Logistics Agency awarded a $119,604.20 delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical products, with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and designates Conshohocken, Pennsylvania as the place of performance, which serves as AmerisourceBergen's corporate headquarters. The delivery order is a child contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical procurement support to military and veteran healthcare systems. The company's substantial IDC with DLA enables it to supply an expansive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems worldwide. This particular delivery order for DARZALEX FASPRO, a specialty pharmaceutical product, exemplifies the company's role as a primary vendor for specialized medications within the DLA's global medical supply chain serving defense and federal health requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $119.6k | 8/6/25 |